Skip to main content
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. — Investor Relations & Filings

Ticker · PMN ISIN · CA74346M1095 LEI · 5299007HZF79F9IAXI53 US Professional, scientific and technical activities
Open in API
Filings indexed 333 across all filing types
Latest filing 2023-09-22 Capital/Financing Update
Country CA Canada
Listing US PMN

About ProMIS Neurosciences Inc.

https://www.promisneurosciences.com/

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company focused on the discovery and development of selective antibody therapeutics for neurodegenerative and other misfolded protein diseases. The company leverages a proprietary technology platform to design and generate antibodies that selectively target toxic oligomers, which are key drivers of diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), and multiple system atrophy (MSA). Its lead product candidate, PMN310, is in clinical development for Alzheimer's disease. The company's approach aims to provide effective treatments while potentially reducing side effects associated with less specific therapies.

Recent filings

Filing Released Lang Actions
POS AM
Capital/Financing Update Classification · 95% confidence The document is a post-effective amendment No. 2 to a Form S-1 registration statement filed with the SEC, converting the registration statement on Form S-1 into a Form S-3. It relates to the registration of securities for resale by selling shareholders and includes a prospectus for the offering of common shares and warrants. The document is a regulatory filing related to securities registration and offering, not a financial report, earnings release, or other report type. It is a formal SEC filing for capital raising and securities registration purposes, fitting the Capital/Financing Update category.
2023-09-22 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933 for the resale of securities by selling securityholders. The text includes details about the securities being registered, the selling securityholders, and the terms of the offering. It is a prospectus related to a securities offering, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration statement document. Form S-3 is a registration statement used for securities offerings and is classified under Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes.
2023-09-22 English
FORM 3 SUBMISSION
Director's Dealing
2023-09-05 English
SC 13G/A
Major Shareholding Notification
2023-09-05 English
SC 13G/A
Major Shareholding Notification
2023-09-05 English
SC 13G
Major Shareholding Notification
2023-08-30 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.